Armen Shanafelt Net Worth & Insider Trades

Armen Shanafelt - Director, Aeglea Biotherapeutics, Inc

As of June 9, 2022

What is Armen Shanafelt's Net Worth?

The current estimated net worth of Aeglea Biotherapeutics, Inc's Director, Armen Shanafelt, is estimated to be about $25.46M . Armen Shanafelt owns about 150,000 units of Aeglea Biotherapeutics, Inc common stock. In the last 6 years at Aeglea Biotherapeutics, Inc, Armen Shanafelt has sold an estimated value of $0 worth.

What is Armen Shanafelt's Past Insider Trading?

Armen Shanafelt's largest purchase order was 150,000 units , worth over $549.69K on December 13, 2021. In total, Armen Shanafelt has made about 8 transactions over 6 years of their time at Aeglea Biotherapeutics, Inc. Armen Shanafelt usually trades in June, with the busiest year in 2021.

Armen Shanafelt

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Armen Shanafelt's' Mailing Address?

  • Mailing address is C/o Lilly Ventures Fund I, Llc 115 W. Washington Street,ste 1680-South Indianapolis IN 46204 IN

Aeglea Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony G. Quinn, M.B Ch.B, Ph.D. 2020 $538,000 $2,089,861 $2,089,861 $25,745 $2,909,606
Anthony G. Quinn, M.B Ch.B, Ph.D. 2019 $518,000 $1,663,919 $1,663,919 $53,857 $2,482,776
Charles N. York II 2020 $415,000 $860,415 $860,415 $8,053 $1,283,468
Charles N. York II 2019 $390,000 $522,424 $522,424 $7,712 $1,085,136
Leslie Sloan, Ph.D. 2020 $370,000 $707,970 $707,970 $20,349 $1,246,319
Leslie Sloan, Ph.D. 2019 $355,000 $632,380 $632,380 $19,843 $1,149,223
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1636282/000156459021019953/agle-def14a_20210608.htm

What are Aeglea Biotherapeutics, Inc's Past Insider Trades?

Aeglea Biotherapeutics, Inc's most recent insider trade came on August 25, 2022 by Marcio Souza who bought 90,000 units worth $50.47K . In the last 6 years, insiders at Aeglea Biotherapeutics, Inc have sold an estimated value of $1.43M and bought an estimated value of $13.71M worth of shares. Insider trading is most common in June, with the busiest year in 2017, 2018 and 2022. The most active traders at the company are Anthony Quinn, President & CEO,  Armen Shanafelt, Director,  and Charles N. York II, Chief Financial Officer and VP .

Aeglea BioTherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1